Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Collaborative Groups / Breast and Gynecologic Cancers Research Group / Completed multi-center (six EDRN and SPORE centers). Phase II/Phase III validation study of more than 75 candidate biomarkers for the early detection of ovarian cancer

Completed multi-center (six EDRN and SPORE centers). Phase II/Phase III validation study of more than 75 candidate biomarkers for the early detection of ovarian cancer

Announcement 06/30/2017

The next EDRN Steering Committee Meeting is from September 12-14, 2017, in Seattle WA. Please click here to register and find out more information about the meeting.

Announcement



EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.